Rheumatology สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
MedEdTalks Rheumatology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on rheumatology topics, such as GCA, ANCA-Associated Vasculitis, Pemphigus Vulgaris, Lupus, Biosimilars, RA, axSpA, irAEs and PSA and includes interviews with Dr. Leonard Calabrese, Dr. Grace Wright, Dr. Jeff Kaine, Dr. John Tesser, Dr. Adam Brown, Dr. John Stone and Dr. Ronald Harris
 
Loading …
show series
 
Hopping in this week to round out my thoughts on ADVOCATE (avacopan in AAV) and covering the recently published AURORA trial for SLE nephritis. Back to the Vasculitis Guidelines Podcast after as soon as they are released!โดย Michael Putman
 
In this episode we'll be introducing the process by which the 2021 ACR/VF guidelines were produced. My guest is Dr. Sharon Chung. She's the director of the UCSF Vasculitis Clinic and the lead investigator on the guideline committee. Please follow along with future episodes - you can find me @ebrheum and the Vasculitis Foundation is at @vasculitisfo…
 
Welcome to the first episode of the Vasculitis Guidelines Podcast! In Episode 1, I interview Joyce Kullman, Executive Director of the Vasculitis Foundation, about collaborating with the ACR in updating these guidelines, and how patients with vasculitis will ultimately benefit from them. We discuss the complex process of updating these critical guid…
 
I stole some time to tackle a pressing issue for rheumatologists - to hold or not to hold immunosuppression in patients who are receiving a COVID19 vaccination. We obviously don't have any data on this, but I have always loved this study on influenza vaccination. PDFs at ebrheum.com/twts and follow me on twitter @ebrheum!…
 
In this podcast, expert clinicians will discuss the importance of empathy in caring for patients with rheumatic diseases. Key aspects of empathy such as listening, eye contact, and reading body language are included. Listen in as Drs. Len and Cassie Calabrese discuss the critical aspects of empathy for rheumatology providers. For CME Credit, comple…
 
In this podcast series, expert clinicians will discuss optimal vaccine practices for rheumatology providers. Herpes zoster, influenza, and pneumococcal vaccine administration will be discussed. Listen in as Dr. Len and Cassandra Calabrese discuss important details on vaccination for rheumatology providers. For CME Credit, complete activity here: ht…
 
In this podcast series, expert clinicians will discuss patient wellness and its importance for rheumatology providers. Key components of wellness such as diet, exercise, and sleep will be discussed. Listen in as Drs. Len Calabrese and Elaine Husni discuss why wellness is important for patients with rheumatic diseases. For CME Credit, complete activ…
 
We have a great show for you this week! Anisha Dua will be moderating a debate between myself and Max Konig on this motion: "Hydroxychloroquine levels should be monitored in patients with SLE." I learned a ton and thoroughly enjoyed it. Be sure to vote on the post-debate twitter poll to decide the winner!…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese review zoster vaccine side effec…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Sax review zoster vaccine safety and efficacy and discus…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Curtis discuss primary risk factors for HZ, incidence ra…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese discuss the clinical manifestati…
 
This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth. Short and to the point - hope you enjoy! I highly recommend checking out the associated graphs - just take a quick peek at some point while listening. Find them on my twitter ha…
 
Active comparator trial! Always my favorite. Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs. Check it out and let me know what you think! @ebrheumโดย Michael Putman
 
Another day, another lupus trial, another round of endpoint shenanigans. Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I try to tackle these issues this week and (hopefully) avoid getting myself in trouble. Hope you enjoy the episode! Let me know what you think @ebrheum on…
 
Great paper to discuss this week - one that may be too good to believe? I highly recommend checking out the pdf first (ebrheum.com/twts) - their graphics are wonderful and do a great job of conveying their message. Also, check out the "2-5-10" rule that I referenced! This is required reading for anyone who rotates with me - easily one of the most u…
 
Quick podcast this week that expands on issues I discuss in Episode 55. Go back and listen to that one first if you have time! I think this is an important issue and it's one I'd like to highlight. Let me know what you think @ebrheum and please share with friends!โดย Michael Putman
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
PEXIVAS has landed! This week I go over the trial and my take on it's results. Impressive undertaking that answered two questions for a subset of patients with AAV - well worth the time to kick back and read the trial in full. Let me know what you think about the podcast @ebrheum!โดย Michael Putman
 
(Yet) another RCT this week! Nice investigator initiated trial with many wonderful strengths and a few crippling flaws. Great opportunity to think about a common problem in practice as well as a separate common problem in trials!โดย Michael Putman
 
In this case-based podcast, Leonard H. Calabrese, DO, and Adam Brown, MD, discuss a patient who presents to the hospital with fever of unknown origin.โดย Leonard Calabrese, MD
 
In this case-based podcast, Leonard H. Calabrese, DO, and Adam Brown, MD, discuss a patient presenting for a second opinion for GCA after initial workup and treatment by her primary care physician.โดย Leonard Calabrese, DO
 
In this case-based podcast, Leonard H. Calabrese, DO, and Ann P. Murchison, MD, MPH, discuss issues related to the workup, diagnosis, and treatment of a patient with new-onset visual symptoms presenting to the emergency department.โดย Leonard Calabrese, DO
 
In this case-based podcast, Leonard H. Calabrese, DO, and Sebastian Unizony, MD, discuss issues related to the workup, diagnosis, and treatment of a patient with complicated GCA.โดย Leonard Calabrese, DO
 
In this case-based podcast, Leonard H. Calabrese, DO, and Sebastian Unizony, MD, discuss issues related to the workup, diagnosis, and treatment of a patient with uncomplicated, or “classic”, GCA.โดย Leonard Calabrese, DO
 
Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. Despite new treatment options for patients with GCA, delays in diagnosis and treatment lead to poor outcomes, such as the increased risk for visual impairments and incidence of heart attacks, transient ischemic attacks, and/or mortality. Diagnosis of GCA rema…
 
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!…
 
Happy New Year! This week Dr. Anisha Dua (@anisha_dua) and Dr. Sarah Fantus (@sarahfantus) debate this motion: "In MTX non-responders with RA, triple therapy (adding HCQ & SSZ) should be first line." Please be sure to VOTE AGAIN on twitter (@ebrheum) after you have listened!โดย Michael Putman
 
This week I go back to a topic from episode 42, the SENSCIS trial and nintedanib for SSc-ILD. The way this medication has been received and a recent article I wrote for The Rheumatologist gave me a nice jumping off point to cover a few more issues from this. Be sure to follow me @EBRheum to let me know what you think! The corresponding article is a…
 
Surprising RCT this week discussing the HOPE trial, which pitted 10mg prednisone against placebo for inflammatory hand OA. I do think this will change my practice, but in a far narrower sense than the headline would suggest. Check it out and find all my other content at ebrheum.com!โดย Michael Putman
 
Rheum4Debate is back! This week we have Dr. Anisha Dua arguing in support of the motion, "Patients with newly diagnosed GCA should start glucocorticoids WITH tocilizumab over glucocorticoids alone." I argue against the motion and Dr. Sarah Fantus was kind enough to moderate. In our pre-debate poll, 51% supported the motion, 34% disagree with the mo…
 
Today I dive into the emerging therapies for psoriatic arthritis, focusing on the IL17i ixekizumab and the recently published SPIRIT-H2H trial. It's a great combination of my favorite thing in RCTs (head to head trials) and my least favorite thing in RCTs (RCTs that were designed in such a way that they don't answer the question I want to know).…
 
In this CME podcast, Dr. John Tesser and Dr. Jeffrey Kaine will discuss the diagnosis and treatment of psoriatic arthritis. To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-psa/cme-information…
 
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.โดย Michael Putman
 
In this CME podcast, Dr. Grace Wright and Dr. Leonard Calabrese will discuss the diagnosis and management of axial spondyloarthritis. Transcript: https://m3.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met008-wrightcalabrese-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_s…
 
In this CME podcast, Dr. Grace Wright and Dr. John Tesser will discuss effective conversations with patients. Transcript: https://m2.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met007-tesserwright-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumat…
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login